{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:46:28Z","timestamp":1762854388749,"version":"build-2065373602"},"reference-count":7,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.gofs.2021.10.008","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T16:01:03Z","timestamp":1635177663000},"page":"105-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Implants contraceptifs Essure\u00ae\u00a0: quelles avanc\u00e9es dans la prise en charge des patientes symptomatiques\u00a0?"],"prefix":"10.1016","volume":"50","author":[{"given":"G.","family":"Chene","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Graesslin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gofs.2021.10.008_bib0060","first-page":"100054","article-title":"Quality of life after laparoscopic removal of Essure sterilization devices","volume":"3","author":"Chene","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol X"},{"key":"10.1016\/j.gofs.2021.10.008_bib0065","first-page":"404","article-title":"Assessment of non-gynecological symptoms before and after removal of the Essure sterilization device: a 6-month follow-up study","volume":"71","author":"Merviel","year":"2019","journal-title":"Minerva Ginecol"},{"key":"10.1016\/j.gofs.2021.10.008_bib0070","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.fertnstert.2019.03.009","article-title":"Social media and Essure hysteroscopic sterilization: a perfect storm","volume":"111","author":"Lindheim","year":"2019","journal-title":"Fertil Steril"},{"key":"10.1016\/j.gofs.2021.10.008_bib0080","unstructured":"CNGOF guidelines\u00a0: fiche technique sur le retrait des device Essure; 2018. http:\/\/www.cngof.fr\/recommandations-pour-la-pratique-clinique\/implant-Essure-infos-professionnelles\/496-device-Essure\u00ae."},{"key":"10.1016\/j.gofs.2021.10.008_bib0085","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1080\/13625187.2021.1925883","article-title":"Surgical techniques for the removal of Essure\u00ae microinserts: a literature review on current practice","volume":"26","author":"Chene","year":"2021","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.gofs.2021.10.008_bib0095","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ejogrb.2020.07.044","article-title":"Potential release of toxic metal elements from Essure device in symptomatic patients: First results of the French Ablimco cohort","volume":"252","author":"Parant","year":"2020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.gofs.2021.10.008_bib0050","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejogrb.2020.04.036","article-title":"Identification of inorganic particles resulting from degradation of ESSURE\u00ae implants: study of 10\u00a0cases","volume":"250","author":"Catinon","year":"2020","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718921002749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718921002749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:41:53Z","timestamp":1762854113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718921002749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S2468718921002749"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2021.10.008","relation":{},"ISSN":["2468-7189"],"issn-type":[{"type":"print","value":"2468-7189"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implants contraceptifs Essure\u00ae\u00a0: quelles avanc\u00e9es dans la prise en charge des patientes symptomatiques\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2021.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}